Scientists have identified proteins that contribute to fibrosis, a condition characterized by scarring, and have found that blocking these proteins may be a potential treatment approach. Research in this area has shown promise for reversing scarring in various organs, including the lungs and liver, although the specific mechanisms and outcomes are still being studied. The findings may have implications for the development of novel therapies for conditions such as scleroderma, liver disease, and lung scarring.